Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3689591013 | Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3689593011 | Cyclophosphamide (as cyclophosphamide monohydrate) 2 g powder for solution for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4562371000052117 | cyklofosfamid (som cyklofosfamidmonohydrat) 2 gram/injektionsflaska, pulver till injektionsvätska | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| cyklofosfamid (som cyklofosfamidmonohydrat) 2 gram/injektionsflaska, pulver till injektionsvätska | Is a | Cyclophosphamide-containing product in parenteral dose form | false | Inferred relationship | Some | ||
| cyklofosfamid (som cyklofosfamidmonohydrat) 2 gram/injektionsflaska, pulver till injektionsvätska | Has active ingredient | Cyclophosphamide (substance) | false | Inferred relationship | Some | ||
| cyklofosfamid (som cyklofosfamidmonohydrat) 2 gram/injektionsflaska, pulver till injektionsvätska | Has manufactured dose form | för injektion | false | Inferred relationship | Some | ||
| cyklofosfamid (som cyklofosfamidmonohydrat) 2 gram/injektionsflaska, pulver till injektionsvätska | Has manufactured dose form | pulver till injektionslösning | false | Inferred relationship | Some | ||
| cyklofosfamid (som cyklofosfamidmonohydrat) 2 gram/injektionsflaska, pulver till injektionsvätska | Has manufactured dose form | Powder for solution for injection | false | Inferred relationship | Some | ||
| cyklofosfamid (som cyklofosfamidmonohydrat) 2 gram/injektionsflaska, pulver till injektionsvätska | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | false | Inferred relationship | Some | 1 | |
| cyklofosfamid (som cyklofosfamidmonohydrat) 2 gram/injektionsflaska, pulver till injektionsvätska | Has presentation strength numerator unit | g | false | Inferred relationship | Some | 1 | |
| cyklofosfamid (som cyklofosfamidmonohydrat) 2 gram/injektionsflaska, pulver till injektionsvätska | Has precise active ingredient | Cyclophosphamide monohydrate (substance) | false | Inferred relationship | Some | 1 | |
| cyklofosfamid (som cyklofosfamidmonohydrat) 2 gram/injektionsflaska, pulver till injektionsvätska | har täljarvärde som visar styrka | två | false | Inferred relationship | Some | 1 | |
| cyklofosfamid (som cyklofosfamidmonohydrat) 2 gram/injektionsflaska, pulver till injektionsvätska | räkning av bas i aktiv ingrediens | ett | false | Inferred relationship | Some | ||
| cyklofosfamid (som cyklofosfamidmonohydrat) 2 gram/injektionsflaska, pulver till injektionsvätska | Has basis of strength substance (attribute) | Cyclophosphamide (substance) | false | Inferred relationship | Some | 1 | |
| cyklofosfamid (som cyklofosfamidmonohydrat) 2 gram/injektionsflaska, pulver till injektionsvätska | har nämnarvärde som visar styrka | ett | false | Inferred relationship | Some | 1 | |
| cyklofosfamid (som cyklofosfamidmonohydrat) 2 gram/injektionsflaska, pulver till injektionsvätska | Has unit of presentation | Vial (unit of presentation) | false | Inferred relationship | Some | ||
| cyklofosfamid (som cyklofosfamidmonohydrat) 2 gram/injektionsflaska, pulver till injektionsvätska | Is a | Product containing only cyclophosphamide in parenteral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| cyklofosfamid (som cyklofosfamidmonohydrat) 2 gram/injektionsflaska, pulver till injektionsvätska | Plays role | Antineoplastic therapeutic role | false | Inferred relationship | Some | ||
| cyklofosfamid (som cyklofosfamidmonohydrat) 2 gram/injektionsflaska, pulver till injektionsvätska | Is a | Medicinal product containing nitrogen mustard derivative and acting as antineoplastic agent (product) | false | Inferred relationship | Some | ||
| cyklofosfamid (som cyklofosfamidmonohydrat) 2 gram/injektionsflaska, pulver till injektionsvätska | Is a | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR